1. Cai, Lixiong, Huo, Zhiqian, Yang, Haiyun, Liu, Lianjun, Sun, Bingyin. . Gene co-expression network analysis identifies BRCC3 as a key regulator in osteogenic differentiation of osteoblasts through a β-catenin signaling dependent pathway. In Iranian journal of basic medical sciences, 22, 173-178. doi:10.22038/IJBMS.2018.29498.7123. https://pubmed.ncbi.nlm.nih.gov/30834083/
2. Huang, Dayong, Nagata, Yasunobu, Grossmann, Vera, Ogawa, Seishi, Makishima, Hideki. 2015. BRCC3 mutations in myeloid neoplasms. In Haematologica, 100, 1051-7. doi:10.3324/haematol.2014.111989. https://pubmed.ncbi.nlm.nih.gov/26001790/
3. Scalavino, Viviana, Piccinno, Emanuele, Valentini, Anna Maria, Giannelli, Gianluigi, Serino, Grazia. 2023. miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis. In Cells, 12, . doi:10.3390/cells12172184. https://pubmed.ncbi.nlm.nih.gov/37681916/
4. Zhang, C H, Qin, K, Tian, S L, Xu, S Y, Shao, X Y. 2022. Identification and Verification of the Ability of Cdk5 to Phosphorylate Deubiquitinating Enzyme BRCC3 In Vitro. In Bulletin of experimental biology and medicine, 172, 701-708. doi:10.1007/s10517-022-05460-z. https://pubmed.ncbi.nlm.nih.gov/35503584/
5. Zhang, Wen, Tao, Shou-Song, Wang, Ting, Yang, Xiao-Ming, Yin, Rong-Hua. 2020. ABRO1 stabilizes the deubiquitinase BRCC3 through inhibiting its degradation mediated by the E3 ubiquitin ligase WWP2. In FEBS letters, 595, 169-182. doi:10.1002/1873-3468.13970. https://pubmed.ncbi.nlm.nih.gov/33107021/
6. Liu, Di, Jin, Shouheng, Cui, Jun. 2022. The TRIM14-USP14-BRCC3 complex epigenetically regulates inflammation through inhibiting OPTN-mediated autophagic degradation of KDM4D. In Autophagy, 18, 2001-2002. doi:10.1080/15548627.2022.2055286. https://pubmed.ncbi.nlm.nih.gov/35311471/